E-LIB Suche - Ergebnisse für: Wójcik-Cichy, Kamila

1

Clinical Perspective on Human Immunodeficiency Virus Care o..:

Parczewski, Miłosz ; Jabłonowska, Elżbieta ; Wójcik-Cichy, Kamila...
Clinical Infectious Diseases. 76 (2023) 10 - p. 1708-1715 , 2023

Link: https://doi.org/10.1093/..

2

Circulation of Human Immunodeficiency Virus 1 A6 Variant in..:

Serwin, Karol ; Chaillon, Antoine ; Scheibe, Kaja...
Clinical Infectious Diseases. 76 (2023) 10 - p. 1716-1724 , 2023

Link: https://doi.org/10.1093/..

3

Gut Microbiota Diversity in HIV-Infected Patients on Succes..:

Jabłonowska, Elżbieta ; Strzelczyk, Joanna ; Piekarska, Anna.
Archivum Immunologiae et Therapiae Experimentalis. 69 (2021) 1 - p. , 2021

Link: https://doi.org/10.1007/..

4

Real-life study of dual therapy based on dolutegravir and r..:

Jabłonowska, Elżbieta ; Siwak, Ewa ; Bociąga-Jasik, Monika...
PLOS ONE. 14 (2019) 1 - p. e0210476 , 2019

Link: https://doi.org/10.1371/..

5

Intestinal Barrier Impairment and Immune Activation in HIV-..:

Wójcik-Cichy, Kamila ; Piekarska, Anna ; Jabłonowska, Elżbieta
Archivum Immunologiae et Therapiae Experimentalis. 66 (2018) 4 - p. 321-327 , 2018

Link: https://doi.org/10.1007/..

6

Control of HBV infection in HIV/HBV co-infected patients tr..:

Wlazłowska, Ewelina ; Piekarska, Anna ; Kamerys, Juliusz..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984790/. , 2022

Link: http://www.ncbi.nlm.nih...

7

Real-life study of dual therapy based on dolutegravir and r..:

Jabłonowska, Elżbieta ; Siwak, Ewa ; Bociąga-Jasik, Monika...
PLoS ONE, T. 14, nr 1. , 2019

Link: https://ruj.uj.edu.pl/xm..

8

The influence of NAFLD on the risk of atherosclerosis and c..:

Wójcik-Cichy, Kamila ; Koślińska-Berkan, Ewa ; Piekarska, Anna
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865905/. , 2018

Link: http://www.ncbi.nlm.nih...

9

Meeting the WHO 90% target : antiretroviral treatment effic..:

Parczewski, Milosz ; Siwak, Ewa ; Leszczyszyn-Pynka, Magdalena...
Journal of the International AIDS Society, T. 20, nr 1. , 2017

Link: https://ruj.uj.edu.pl/xm..

10

Real-life study of dual therapy based on dolutegravir and r..:

Elżbieta Jabłonowska ; Ewa Siwak ; Monika Bociąga-Jasik...
https://doi.org/10.1371/journal.pone.0210476. , 2019

Link: https://doi.org/10.1371/..

11

Secretory leukocyte protease inhibitor modulates FcεRI-depe..:

Kwiecinska, Patrycja ; Kwitniewski, Mateusz ; Kwiecien, Kamila...
International Immunopharmacology. 122 (2023) - p. 110631 , 2023

Link: https://doi.org/10.1016/..

12

Alternative splicing is not a key source of chemerin isofor..:

Kwiecien, Kamila ; Majewski, Pawel ; Bak, Maciej...
Molecular Biology Reports. 50 (2023) 3 - p. 2521-2529 , 2023

Link: https://doi.org/10.1007/..

13

Soluble mediators in the function of the epidermal-immune-n..:

Oleszycka, Ewa ; Kwiecien, Kamila ; Kwiecinska, Patrycja...
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

14

The genus Bilharziella vs. other bird schistosomes in snail..:

Stanicka, Anna ; Migdalski, Łukasz ; Zając, Kamila Stefania...
Knowledge & Management of Aquatic Ecosystems. , 2021

Link: https://doi.org/10.1051/..

15

The methylation status of the chemerin promoter region loca..:

Kwiecien, Kamila ; Brzoza, Piotr ; Bak, Maciej...
Scientific Reports. 10 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..